Safety and Efficacy of Amphotericin B Colloidal Dispersion

Publisher： Karger

E-ISSN： 1421-9794|45|1|67-76

ISSN： 0009-3157

Source： Chemotherapy, Vol.45, Iss.1, 1999-07, pp. : 67-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 15-26

Karger

Access to resources Recommend Favorite

Treatment of Visceral Leishmaniasis with Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 54-66

Karger

Access to resources Recommend Favorite

Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Candida spp

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Aspergillus spp

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 34-38

Karger

Access to resources Recommend Favorite

Renal Sparing by Amphotericin B Colloidal Dispersion: Clinical Experience in 572 Patients

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 39-47

Karger

Access to resources Recommend Favorite